XML 26 R5.htm IDEA: XBRL DOCUMENT v3.24.0.1
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Thousands, $ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Income Statement [Abstract]      
Revenue, net $ 518,590 $ 405,926 $ 332,381
Cost of goods sold (363,470) (271,363) (196,409)
Gross profit 155,120 134,563 135,972
Operating expenses      
General and administrative expenses 158,739 137,089 116,665
Settlement expense 0 5,000 36,511
Total operating expenses 158,739 142,089 153,176
Operating loss (3,619) (7,526) (17,204)
Other (expense) income      
Interest expense (36,984) (32,436) (63,989)
Other, net 25,843 756 256
Total other expense (11,141) (31,680) (63,733)
Loss before income taxes (14,760) (39,206) (80,937)
Income tax expense (33,454) (41,693) (41,720)
Net loss $ (48,214) $ (80,899) $ (122,657)
Net loss per share attributable to Class A and Class B stockholders of Ascend Wellness Holdings, Inc. — basic (in dollars per share) $ (0.24) $ (0.44) $ (0.82)
Net loss per share attributable to Class A and Class B stockholders of Ascend Wellness Holdings, Inc. — diluted (in dollars per share) $ (0.24) $ (0.44) $ (0.82)
Weighted-average common shares outstanding — basic (in shares) 199,154 183,381 149,434
Weighted-average common shares outstanding —diluted (in shares) 199,154 183,381 149,434